Clear Creek Financial Management LLC Acquires Shares of 757 Cigna Group $CI

Clear Creek Financial Management LLC bought a new position in shares of Cigna Group (NYSE:CI) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 757 shares of the health services provider’s stock, valued at approximately $250,000.

Other hedge funds also recently made changes to their positions in the company. Valeo Financial Advisors LLC boosted its stake in shares of Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares during the period. Nuveen LLC bought a new stake in shares of Cigna Group in the first quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after buying an additional 1,094,327 shares during the period. GQG Partners LLC boosted its stake in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after buying an additional 865,092 shares during the period. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after buying an additional 457,052 shares during the period. 86.99% of the stock is owned by institutional investors.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Cigna Group Trading Down 1.7%

Shares of Cigna Group stock opened at $301.00 on Friday. The firm has a market capitalization of $80.35 billion, a PE ratio of 16.43, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm’s 50 day moving average is $294.68 and its 200 day moving average is $309.23. Cigna Group has a 1 year low of $256.89 and a 1 year high of $358.88.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.15 by $0.05. The company had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were issued a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. Cigna Group’s payout ratio is 32.97%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CI shares. Royal Bank Of Canada reiterated an “outperform” rating and issued a $371.00 price target on shares of Cigna Group in a research note on Thursday, June 26th. Guggenheim restated a “buy” rating and issued a $350.00 target price (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Truist Financial set a $375.00 target price on shares of Cigna Group in a research report on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Finally, Wells Fargo & Company boosted their target price on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research report on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $372.69.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.